David W. Boulton

7.1k citations
146 papers · 5.0k indexed · 1 hit paper · h-index 39
Topics
Diabetes Treatment and Management (76 papers)Pancreatic function and diabetes (38 papers)Diabetes Management and Research (25 papers)
Journals
SHILAP Revista de lepidopterologíaAnalytical ChemistryDiabetes Care

In The Last Decade

David W. Boulton

140 papers receiving 4.8k citations

Hit Papers

Why do SGLT2 inhibitors reduce heart failure hospitalizat...20172026202020232017100200300

Peers

David W. Boulton
Comparison fields: 5 of 129
  • Endocrinology, Diabetes and Metabolism 2.6k
  • Molecular Biology 1.6k
  • Surgery 1.4k
  • Pharmacology 630
  • Oncology 610
Replace Giuseppe Derosa with:
Giuseppe Derosa Italy
Juan Tamargo Spain
Pamela Maffioli Italy
Peter W. Stacpoole United States
Morris J. Brown United Kingdom
Garry G. Graham Australia
Aziz Karim United States
Munehiro Kitada Japan
Fatemeh Akhlaghi United States
Christian Funck‐Brentano France
David W. Boulton relative to Giuseppe Derosa Italy Giuseppe Derosa's profile →
Citations per field
00.5×1.5×1.9×
Giuseppe Derosa · 1×
Citations per year

Countries citing papers authored by David W. Boulton

Since Specialization
Citations

This map shows the geographic impact of David W. Boulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Boulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Boulton more than expected).

Fields of papers citing papers by David W. Boulton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Boulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Boulton. The network helps show where David W. Boulton may publish in the future.

Co-authorship network of co-authors of David W. Boulton

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Boulton. A scholar is included among the top collaborators of David W. Boulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Boulton. David W. Boulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 14
3 3
4 1
5 6
6 10
7 1
8 4
9 5
10 25
11 12
12 24
13 9
14 39
15
Pharmacokinetics of the dipeptidyl peptidase-4 inhibitor saxagliptin in subjects with renal impairment
7
16 38
17 43
18 17
19 114
20 21

About David W. Boulton

David W. Boulton is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Family Practice, having authored 146 papers that have together received 5.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (76 papers), Pancreatic function and diabetes (38 papers) and Diabetes Management and Research (25 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.6k citations), Pharmacology (560 citations) and Pharmacology (630 citations). David W. Boulton has collaborated with scholars based in United States, Sweden and Poland. Frequent co-authors include Frank LaCreta, C. Lindsay DeVane, Sreeneeranj Kasichayanula, J. Paul Fawcett, Steven C. Griffen, John S. Markowitz, Peter J. Greasley, Marc Pfister, Thomas Walle and Xiaoni Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026